InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AEON Biopharma, Inc.

AEON Clue Score43
United States Fiscal year ends December CIK 0001837607
$0.25 -11.01% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.25 −97.49% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 12 Apr 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2021Operating income−1.9Net income8.2Fiscal year 2022Operating income−48.4Net income−52.6 −740.9%EPS, diluted−0.38Fiscal year 2024Operating income73.0Net income42.0EPS, diluted72.93Fiscal year 2025Operating income−12.8Net income−39.2 −193.4%EPS, diluted−3.95
FY2021FY2022FY2024FY2025
Operating income −1.9 −48.4 73.0 −12.8
Net income 8.2 −52.6 42.0 −39.2
Growth −740.9% −193.4%
EPS, diluted n/a −0.38 72.93 −3.95

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−1.5Fiscal year 2022Operating cash flow−35.6Capital expenditure−0.3Free cash flow−35.9Fiscal year 2024Operating cash flow−20.3Fiscal year 2025Operating cash flow−17.3Capital expenditure−0.0Free cash flow−17.3
FY2021FY2022FY2024FY2025
Operating cash flow −1.5 −35.6 −20.3 −17.3
Capital expenditure n/a −0.3 n/a −0.0
Free cash flow n/a −35.9 n/a −17.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash0.5Shareholders’ equity−16.9Fiscal year 2022Cash9.7Shareholders’ equity−287.5Fiscal year 2024Cash0.0Shareholders’ equity−28.6Fiscal year 2025Cash3.0Shareholders’ equity−55.0
FY2021FY2022FY2024FY2025
Cash 0.5 9.7 0.0 3.0
Shareholders’ equity −16.9 −287.5 −28.6 −55.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Spending
n/a n/a 0.0% n/a
Returns
3.0% −487.6% 1,336.9% −705.4%
Balance and payout
6.5% 1,329.0% 1,009.3% 1,089.7%